Bladder Cancer Clinical Trial

A Study of Nivolumab or Nivolumab Plus Experimental Medication BMS-986205 With or Without Bacillus Calumette-Guerin (BCG) in BCG Unresponsive Bladder Cancer That Has Not Invaded Into the Muscle Wall of the Bladder

Summary

A study to evaluate the safety and tolerability of nivolumab or nivolumab Plus BMS-986205 with or without BCG in BCG-Unresponsive non-muscle invasive Bladder Cancer.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Pathologically demonstrated BCG-unresponsive, carcinoma in situ (CIS)-containing high-risk non-muscle-invasive bladder cancer (NMIBC) defined as CIS with or without papillary component
Participants must have CIS to be eligible.
Predominant histologic component (> 50%) must be urothelial (transitional cell) carcinoma
Eastern Cooperative Oncology Group (ECOG) performance status 0-1

Exclusion Criteria:

Sign of locally advanced disease or metastatic bladder cancer
Urothelial cancer (UC) in the upper genitourinary tract (kidneys, renal collecting systems, ureters) within 24 months of enrollment
Prior immuno-oncology therapy

Other protocol-defined inclusion/exclusion criteria apply

Study is for people with:

Bladder Cancer

Phase:

Phase 2

Estimated Enrollment:

69

Study ID:

NCT03519256

Recruitment Status:

Completed

Sponsor:

Bristol-Myers Squibb

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 85 Locations for this study

See Locations Near You

Local Institution - 0044
Los Angeles California, 90033, United States
Local Institution - 0081
Riverside California, 92505, United States
Local Institution - 0087
San Francisco California, 94158, United States
Local Institution - 0125
Tampa Florida, 33612, United States
Local Institution - 0056
Hapeville Georgia, 30354, United States
Local Institution - 0023
New Lenox Illinois, 60451, United States
Wichita Urology Group
Wichita Kansas, 67226, United States
Local Institution - 0001
Baltimore Maryland, 21287, United States
Local Institution - 0077
Ann Arbor Michigan, 48109, United States
University Of Minnesota
Minneapolis Minnesota, 55455, United States
Local Institution - 0040
Omaha Nebraska, 68114, United States
Local Institution - 0144
New Brunswick New Jersey, 08903, United States
Deleware Valley Urology, LLC
Voorhees New Jersey, 08043, United States
Local Institution - 0051
New York New York, 10016, United States
Local Institution - 0058
Columbus Ohio, 43212, United States
Local Institution - 0036
Bala-Cynwyd Pennsylvania, 19004, United States
Local Institution - 0049
Charleston South Carolina, 29425, United States
Local Institution - 0002
Myrtle Beach South Carolina, 29572, United States
Local Institution - 0057
Chattanooga Tennessee, 37403, United States
Urology Clinics Of North Texas, Pa
Dallas Texas, 75231, United States
Houston Methodist Hospital
Houston Texas, 77030, United States
Local Institution - 0048
Houston Texas, 77030, United States
Local Institution - 0047
Lubbock Texas, 79415, United States
Urology San Antonio Research, Pa
San Antonio Texas, 78229, United States
Local Institution - 0141
Seattle Washington, 98195, United States
Local Institution
Capital Federal Buenos Aires, 1426, Argentina
Local Institution
Ciudad Autónoma de Buenos Aires Buenos Aires, 1280, Argentina
Local Institution
Ciudad Autonoma Buenos Aires Distrito Federal, 1118, Argentina
Local Institution
Viedma RIO Negro, 8500, Argentina
Instituto Oncologico De Cordoba
Cordoba , 5000, Argentina
Local Institution - 0137
Mendoza , 5500, Argentina
Local Institution
Camperdown New South Wales, 2050, Australia
Local Institution - 0148
St Leonards New South Wales, 2065, Australia
Local Institution - 0072
Fortaleza Ceara, 60135, Brazil
Local Institution - 0151
Curitiba Parana, 80810, Brazil
Local Institution - 0073
Porto Alegre RIO Grande DO SUL, 91350, Brazil
Local Institution
Itacorubi, Florianopolis Santa Catarina, 88034, Brazil
Local Institution - 0078
Jau Sao Paulo, 17210, Brazil
Local Institution - 0150
Rio de Janeiro , 20230, Brazil
Local Institution
Sao Paulo , 01246, Brazil
Local Institution - 0143
North York Ontario, M2K 1, Canada
Local Institution - 0086
Toronto Ontario, M4N 3, Canada
Local Institution - 0084
Toronto Ontario, M5G 2, Canada
Local Institution
Quebec , G1R 2, Canada
Local Institution - 0154
Santiago Metropolitana, 84203, Chile
Local Institution
Santiago Metropolitana, , Chile
Local Institution
Beijing Beijing, 10002, China
Local Institution
Beijing Beijing, 10003, China
Local Institution - 0116
Beijing Beijing, 10014, China
Local Institution
Beijing Beijing, 10019, China
Local Institution
Chongqing Chongqing, 40003, China
Local Institution
Fuzhou Fujian, 35000, China
Local Institution
Guangzhou Guangdong, 51008, China
Local Institution
Nanjing Jiangsu, 21000, China
Local Institution
Nanchang Jiangxi, , China
Local Institution
Jinan Shandong, 25001, China
Local Institution
Yantai Shandong, 26400, China
Local Institution
Shanghai Shanghai, 20002, China
Local Institution - 0094
Shanghai Shanghai, 20003, China
Local Institution
Shanghai Shanghai, 20004, China
Local Institution
Chengdu Sichuan, 61004, China
Local Institution
Tianjin Tianjin, 30021, China
Local Institution
Hang'zhou Zhejiang, 31000, China
Local Institution - 0028
Angers Maine-et-Loire, 49933, France
Hopital Pellegrin
Bordeaux , 33000, France
Hopital Claude Huriez
LILLE Cedex , 59037, France
Nouvel Hopital Civil Chru De Strasbourg
Strasbourg Cedex , 67091, France
Hopital Foch
Suresnes , 92151, France
Local Institution
Hong Kong , , Hong Kong
Local Institution - 0021
Milano , 20133, Italy
Local Institution - 0022
Napoli , 80131, Italy
Local Institution - 0020
Pisa , 56126, Italy
Local Institution - 0062
Tuxtla Gutierrez Chiapas, 29083, Mexico
Cryptex Investigacion Clinica Sa de Cv
Ciudad de Mexico Distrito Federal, 06100, Mexico
Local Institution
Amsterdam , 1066 , Netherlands
Local Institution - 0003
Nijmegen , 6525G, Netherlands
Local Institution - 0005
Utrecht , 3584C, Netherlands
Local Institution
Omsk , 64401, Russian Federation
Local Institution
Saint-Petersburg , 19404, Russian Federation
Local Institution
Saint-Petersburg , 19903, Russian Federation
Local Institution
Madrid , 28041, Spain
Local Institution
Malaga , 29010, Spain
Local Institution
Santander , 39008, Spain
Local Institution - 0136
Valencia , 46010, Spain
Local Institution - 0080
Istanbul , 34300, Turkey
Local Institution
Chelmsford Essex, CM1 7, United Kingdom
Local Institution
London Greater London, N18 1, United Kingdom
Local Institution - 0013
Southampton Hampshire, SO16 , United Kingdom
Local Institution
Lancaster , LA1 4, United Kingdom

How clear is this clinincal trial information?

Study is for people with:

Bladder Cancer

Phase:

Phase 2

Estimated Enrollment:

69

Study ID:

NCT03519256

Recruitment Status:

Completed

Sponsor:


Bristol-Myers Squibb

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.